Neuromodulation device for treating MS-related gait deficit receives FDA authorisation

Retrieved on: 2021-06-18 09:21:17

Tags for this article:

Click the tags to see associated articles and topics

Neuromodulation device for treating MS-related gait deficit receives FDA authorisation. View article details on hiswai:

Excerpt

Cambridge Consultants and Helius Medical Technologies have confirmed their “groundbreaking” Portable Neuromodulation Stimulator (PoNS) ...

Article found on: neuronewsinternational.com